Midazolam: Béda antarrépisi

Konten dihapus Konten ditambahkan
Uchup19 (obrolan | kontribusi)
Uchup19 (obrolan | kontribusi)
Tidak ada ringkasan suntingan
Baris ka-1:
{{Dipaké|}}
 
'''Midazolam''' mangrupa [[ubar]] nu kaasup kana golongan [[bénzodiazépin]].<ref>{{Cite web|url=https://medlineplus.gov/druginfo/meds/a609003.html|title=Midazolam: MedlinePlus Drug Information|website=medlineplus.gov|language=en|accessdate=2019-12-13}}</ref> Minangka ubar panenang, ieu midazolam mibanda sipat [[ansiolitik]], palemes [[otot]], [[antikonvulsan]], [[sédatif]], [[hipnotik]], jeung [[amnésik]].<ref name=":0">{{Cite web|url=https://www.drugbank.ca/drugs/DB00683|title=Midazolam|website=www.drugbank.ca|accessdate=2019-12-13}}</ref> Dina larapanna ieu midazolam geus dipaké dina rupa-rupa kagiatan biomédis, kayaning [[bedah jantung]], ogé dina prosedur [[éndoskopi]] minangka ubar pra[[Anéstési|-anéstési]], minangka tatambah pikeun anéstési lokal, sarta dipaké ogé ku [[dokter huntu]].<ref name=":0" /> Pamakéan midazolam bisa ku cara [[oral]], [[réktal]], [[intranasal]], [[intramuskuler]], jeung jalur [[intravéna]].<ref name=":0" /> Midazolam kagolong ubar bénzodiazépin anu unik, lantaran onsét éfékna nu gancang sarta durasi tindakan anu pondok.<ref name=":0" />
 
Midazolam guna pisan pikeun ngubaran [[sakalor]].<ref>{{Cite journal|last=Smith|first=Rob|last2=Brown|first2=Janis|date=2017-2|title=Midazolam for status epilepticus|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313252/|journal=Australian Prescriber|volume=40|issue=1|pages=23–25|doi=10.18773/austprescr.2017.005|issn=0312-8008|pmc=5313252|pmid=28246432}}</ref> Sok sanajan kitu, aya éfék sagigireunna kayaning napas jadi eungap, tekenan getih jadi rendah, sarta [[tunduh]].<ref>{{Cite web|url=https://www.drugs.com/monograph/midazolam-hydrochloride.html|title=Midazolam Hydrochloride Monograph for Professionals|website=Drugs.com|language=en|accessdate=2019-12-13}}</ref> Taak kana éfékna<ref>{{Cite book|title=StatPearls|url=http://www.ncbi.nlm.nih.gov/books/NBK537321/|publisher=StatPearls Publishing|date=2019|location=Treasure Island (FL)|pmid=30726006|first=Thejasvi N.|last=Lingamchetty|first2=Abdolreza|last2=Saadabadi}}</ref> jeung [[sakaw]] mah bisa kajadian mun ieu ubar dikonsumsi katutuluyan.<ref>{{Cite journal|last=Mets|first=B.|last2=Horsell|first2=A.|last3=Linton|first3=D. M.|date=1991-01|title=Midazolam-induced benzodiazepine withdrawal syndrome|url=https://www.ncbi.nlm.nih.gov/pubmed/1996748|journal=Anaesthesia|volume=46|issue=1|pages=28–29|doi=10.1111/j.1365-2044.1991.tb09309.x|issn=0003-2409|pmid=1996748}}</ref> Taun 1974 ieu midazolam dipaténkan tuluy taun 1982 mimiti dipaké secara médis.<ref name=":1">{{Cite web|url=https://www.medicinenet.com/midazolam-injection/article.htm|title=midazolam injection (Versed): Uses, Side Effects & Dosage|website=MedicineNet|language=en|accessdate=2020-01-13}}</ref> Kiwari ieu ubar geus sayaga minangka ubar teu bisa kahontal lantaran waragadna teu pati mahal sarta kaasup ubar generik.<ref name=":1" />
 
== Kontraindikasi ==